评估和治疗机械泵血栓和溶血。
Evaluation and treatment of pump thrombosis and hemolysis.
机构信息
1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
出版信息
Ann Cardiothorac Surg. 2014 Sep;3(5):490-5. doi: 10.3978/j.issn.2225-319X.2014.09.01.
Abstract
Ventricular assist devices (VADs) are not fully biocompatible, and are therefore predisposed to device thrombosis and subsequent pump dysfunction. Clinically significant hemolysis in VADs most often occurs as a result of device thrombosis, but can also be caused by other factors. Herein we describe the evaluation and management of VAD thrombosis and hemolysis.
摘要
心室辅助装置（VAD）并非完全生物相容，因此易发生装置血栓形成和随后的泵功能障碍。VAD 中临床上显著的溶血最常因装置血栓形成引起，但也可能由其他因素引起。本文介绍了 VAD 血栓形成和溶血的评估和处理。
相似文献
1
Evaluation and treatment of pump thrombosis and hemolysis.评估和治疗机械泵血栓和溶血。
Ann Cardiothorac Surg. 2014 Sep;3(5):490-5. doi: 10.3978/j.issn.2225-319X.2014.09.01.
2
Multi-indicator analysis of mechanical blood damage with five clinical ventricular assist devices.五种临床心室辅助装置的血液机械损伤的多指标分析。
Comput Biol Med. 2022 Dec;151(Pt A):106271. doi: 10.1016/j.compbiomed.2022.106271. Epub 2022 Nov 5.
3
Comprehensive review of hemolysis in ventricular assist devices.心室辅助装置中溶血的综合综述。
World J Cardiol. 2020 Jul 26;12(7):334-341. doi: 10.4330/wjc.v12.i7.334.
4
Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.新型磁悬浮 CH-VAD 泵与 HVAD 和 HeartMate II 泵的血流和血液损伤潜力的计算特性。
Int J Artif Organs. 2020 Oct;43(10):653-662. doi: 10.1177/0391398820903734. Epub 2020 Feb 11.
5
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.左心室辅助装置的耐久性：机械循环辅助机构注册研究（INTERMACS）2006 年至 2011 年。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):437-41.e1. doi: 10.1016/j.jtcvs.2013.02.018. Epub 2013 Mar 13.
6
A New Mathematical Numerical Model to Evaluate the Risk of Thrombosis in Three Clinical Ventricular Assist Devices.一种用于评估三种临床心室辅助装置血栓形成风险的新型数学数值模型。
Bioengineering (Basel). 2022 May 27;9(6):235. doi: 10.3390/bioengineering9060235.
7
Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.乳酸脱氢酶在心室辅助装置溶血特性的体外评估中
Artif Organs. 2017 Nov;41(11):E274-E284. doi: 10.1111/aor.12943. Epub 2017 Jul 19.
8
Flow features and device-induced blood trauma in CF-VADs under a pulsatile blood flow condition: A CFD comparative study.脉动血流条件下CF-VADs中的血流特征和装置引起的血液损伤：一项CFD对比研究。
Int J Numer Method Biomed Eng. 2018 Feb;34(2). doi: 10.1002/cnm.2924. Epub 2017 Oct 6.
9
Clinical implications of LDH isoenzymes in hemolysis and continuous-flow left ventricular assist device-induced thrombosis.乳酸脱氢酶同工酶在溶血和连续流左心室辅助装置诱导的血栓形成中的临床意义。
Artif Organs. 2020 Mar;44(3):231-238. doi: 10.1111/aor.13565. Epub 2019 Oct 6.
10
[Temporary use of centrifugal pump for pump thrombosis in patients with paracorporeal ventricular assist device].[体外心室辅助装置患者泵血栓形成时离心泵的临时应用]
Kyobu Geka. 2015 May;68(5):323-8; discussion 328-31.
引用本文的文献
1
Left ventricular assist device exchanges: A safe and effective strategy in the era of limited organ availability.左心室辅助装置更换：在器官供应有限时代的一种安全有效的策略。
Int J Artif Organs. 2025 Aug;48(8):566-574. doi: 10.1177/03913988251351116. Epub 2025 Jun 25.
2
Thrombotic and Hemorrhagic Complications Following Left Ventricular Assist Device Placement: An Emphasis on Gastrointestinal Bleeding, Stroke, and Pump Thrombosis.左心室辅助装置植入后的血栓形成和出血并发症：重点关注胃肠道出血、中风和泵血栓形成。
Cureus. 2023 Dec 27;15(12):e51160. doi: 10.7759/cureus.51160. eCollection 2023 Dec.
3
A gravity-driven droplet fluidic point-of-care test.一种重力驱动的微滴式即时检测
Device. 2023 Jul 21;1(1). doi: 10.1016/j.device.2023.100009. Epub 2023 Jul 11.
4
Accelerated LVAD pump thrombosis in COVID-19 patient: Case report and mini review.COVID-19 患者加速的 LVAD 泵血栓形成：病例报告和小型综述。
J Card Surg. 2022 Dec;37(12):5313-5319. doi: 10.1111/jocs.17097. Epub 2022 Nov 8.
5
Intraoperative pump thrombosis (PT) in HeartMate (HM) III.HeartMate III 术中泵血栓形成（PT）。
J Card Surg. 2022 Nov;37(11):3912-3915. doi: 10.1111/jocs.16941. Epub 2022 Sep 18.
6
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide.左心室辅助装置患者急诊护理的多学科方法：实用指南。
Front Cardiovasc Med. 2022 Aug 22;9:923544. doi: 10.3389/fcvm.2022.923544. eCollection 2022.
7
DNA Origami-Platelet Adducts: Nanoconstruct Binding without Platelet Activation.DNA 折纸血小板缀合物：纳米构建体结合而不激活血小板。
Bioconjug Chem. 2022 Jul 20;33(7):1295-1310. doi: 10.1021/acs.bioconjchem.2c00197. Epub 2022 Jun 22.
8
Sudden severe left ventricular assist device inflow cannula obstruction caused by huge thrombus after closure of mechanical aortic valve: case report.机械主动脉瓣关闭后巨大血栓导致左心室辅助装置流入管突然严重阻塞：病例报告。
J Artif Organs. 2022 Dec;25(4):364-367. doi: 10.1007/s10047-022-01332-5. Epub 2022 Apr 20.
9
Non-Surgical Resolution of Inflow Cannula Obstruction of a Left Ventricular Assist Device: A Case Report.左心室辅助装置流入插管梗阻的非手术解决方法：一例报告
J Chest Surg. 2021 Dec 5;54(6):543-546. doi: 10.5090/jcs.21.075.
10
Device-Induced Hemostatic Disorders in Mechanically Assisted Circulation.机械循环辅助中器械相关止血障碍。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620982374. doi: 10.1177/1076029620982374.
本文引用的文献
1
Outcomes in HeartMate II Patients With No Antiplatelet Therapy: 2-Year Results From the European TRACE Study.未接受抗血小板治疗的HeartMate II患者的结局：欧洲TRACE研究的2年结果
Ann Thorac Surg. 2017 Apr;103(4):1262-1268. doi: 10.1016/j.athoracsur.2016.07.072. Epub 2016 Oct 13.
2
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.INTERMACS（机械辅助循环支持机构注册研究）分析 HeartMate II 左心室辅助装置中的泵血栓形成。
J Heart Lung Transplant. 2014 Jan;33(1):12-22. doi: 10.1016/j.healun.2013.11.001. Epub 2013 Nov 27.
3
Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.HeartMate II 连续血流左心室辅助装置中的器械血栓形成：一种多因素现象。
J Heart Lung Transplant. 2014 Jan;33(1):51-9. doi: 10.1016/j.healun.2013.10.005. Epub 2013 Nov 28.
4
Unexpected abrupt increase in left ventricular assist device thrombosis.左心室辅助装置血栓形成的意外急剧增加。
N Engl J Med. 2014 Jan 2;370(1):33-40. doi: 10.1056/NEJMoa1313385. Epub 2013 Nov 27.
5
Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.超声心动图在疑似持续血流左心室辅助装置血栓形成导致的血管内溶血患者中的作用。
JACC Cardiovasc Imaging. 2013 Nov;6(11):1129-40. doi: 10.1016/j.jcmg.2013.06.006. Epub 2013 Oct 2.
6
VADoscopy: a novel intraoperative technique to evaluate HeartMate II left ventricular assist device inflow obstruction and thrombosis.经食管超声心动图检查：评估 HeartMate II 左心室辅助装置流入道梗阻和血栓形成的新术中技术。
ASAIO J. 2013 Nov-Dec;59(6):671-4. doi: 10.1097/MAT.0b013e3182a8749f.
7
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.新型超声心动图斜坡试验优化速度和诊断连续血流左心室辅助装置中装置血栓形成：哥伦比亚斜坡研究。
J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75. doi: 10.1016/j.jacc.2012.07.052. Epub 2012 Oct 3.
8
Gastrointestinal bleeding with the HeartMate II left ventricular assist device.HeartMate II 左心室辅助装置相关的胃肠道出血。
J Heart Lung Transplant. 2012 Jul;31(7):715-8. doi: 10.1016/j.healun.2012.02.015. Epub 2012 Mar 14.
9
Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction.门控心脏 CT 血管造影在左心室辅助装置功能障碍评估中的应用。
ASAIO J. 2011 Jan-Feb;57(1):32-7. doi: 10.1097/MAT.0b013e3181fd3405.
10
Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.对于使用 HeartMate II 左心室辅助系统的患者，术后可能不需要肝素即可过渡到长期华法林治疗。
J Heart Lung Transplant. 2010 Jun;29(6):616-24. doi: 10.1016/j.healun.2010.02.003. Epub 2010 Apr 18.
Zotero 插件